TNF-alpha Drives Matrix Metalloproteinase-9 in Squamous Oral Carcinogenesis
Overview
Affiliations
Objectives/hypothesis: It is well known that invasion is a seminal event in the progression of oral and other head and neck carcinoma sites. We have previously demonstrated tumor necrosis factor (TNF)-alpha and its dependent cytokines are upregulated in saliva during oral carcinogenesis. TNF-dependent events stimulate nuclear factor (NF)-kappaB and many NF-kappaB-dependent genes are associated with cancer progression.
Materials And Methods: In the present study, we examined NF-kappaB stimulation of matrix metalloproteinase (MMP)-9 in a precancerous keratinocyte cell line that models leukoplakia (Rhek cells). We stimulated Rhek cells with both TNF-alpha and phorbol myristate acetate, known stimulants of NF-kappaB. We then assayed MMP-9 transcription and secretion by luciferase reporter genes, quantitative real-time polymerase chain reaction, and fluorometric enzyme-linked immunosorbent serologic assay.
Results: We discovered that the MMP-9 promoter was significantly stimulated by phorbol myristate acetate and TNF-alpha on luciferase reporter gene assays. Further, we uncovered that functional MMP-9 promoter activation was accompanied by significant increases in MMP-9 gene expression, as judged by quantitative real-time polymerase chain reaction. Functional activation of the MMP-9 protein was stimulated by TNF-alpha and PMA on a fluorescent enzyme-linked immunosorbent serologic assay. Finally, we searched our salivary proteomic database for increases in MMP-9 and discovered it was the third most significant protein in salivas of oral cavity cancer patients over normal controls.
Conclusions: We conclude the milieu cytokine, TNF-alpha, has the capacity to provide stimulation of events related to early invasion of oral cavity cancer, as judged by its ability to stimulate MMP-9.
The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma.
Li K, Zeng X, Liu P, Zeng X, Lv J, Qiu S J Inflamm Res. 2023; 16:4301-4315.
PMID: 37791117 PMC: 10544098. DOI: 10.2147/JIR.S428358.
Targeted therapy for head and neck squamous cell carcinoma microenvironment.
Guo Z, Li K, Liu P, Zhang X, Lv J, Zeng X Front Med (Lausanne). 2023; 10:1257898.
PMID: 37711747 PMC: 10498927. DOI: 10.3389/fmed.2023.1257898.
Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells.
Le M, Wuertz B, Biel M, Thompson R, Ondrey F Laryngoscope Investig Otolaryngol. 2022; 7(4):982-987.
PMID: 36000031 PMC: 9392394. DOI: 10.1002/lio2.772.
Gupta S, Nigam K, Srivastav R, Ahmad M, Mahdi A, Sanyal S Oral Maxillofac Surg. 2021; 26(1):33-43.
PMID: 33779868 DOI: 10.1007/s10006-020-00929-5.
Kamarajan P, Ateia I, Shin J, Fenno J, Le C, Zhan L PLoS Pathog. 2020; 16(10):e1008881.
PMID: 33002094 PMC: 7529280. DOI: 10.1371/journal.ppat.1008881.